Anastrazole and Clomiphene to Evaluate Hypogonadal Symptoms and Erectile Function
Status:
Completed
Trial end date:
2017-03-08
Target enrollment:
Participant gender:
Summary
This study evaluates anastrazole and clomiphene in the improvement in hypogonadal symptoms
and erectile function. Each subject will receive Anastrazole 1 mg/day, clomiphene 25 mg/day
and placebo in randomized schedule of 8 week intervals.